naltrexone has been researched along with Dry Eye in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS | 1 |
McLaughlin, PJ; Sassani, JW; Titunick, MB; Zagon, IS | 1 |
Immonen, JA; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
Klocek, MS; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
1 review(s) available for naltrexone and Dry Eye
Article | Year |
---|---|
Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.
Topics: Animals; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Dry Eye Syndromes; Enkephalins; Humans; Insulin; Naltrexone; Narcotic Antagonists; Receptors, Opioid | 2021 |
3 other study(ies) available for naltrexone and Dry Eye
Article | Year |
---|---|
Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Male; Naltrexone; Narcotic Antagonists; Rabbits; Rats; Rats, Sprague-Dawley; Tears | 2019 |
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Topics: Administration, Topical; Animals; Blood Glucose; Corneal Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dry Eye Syndromes; Epithelium, Corneal; Fluorophotometry; Intraocular Pressure; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Ophthalmic Solutions; Re-Epithelialization; Tears; Wound Healing | 2014 |
Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.
Topics: Administration, Topical; Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Sensation; Tears | 2009 |